{
    "2019-05-29": [
        [
            {
                "time": "",
                "original_text": "中国药企巨头收入构成（附图表）",
                "features": {
                    "keywords": [
                        "中国药企",
                        "收入构成",
                        "巨头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药】立足医改主线，精选优质个股——医药行业周报——中性（联系人：甘英健，陈晨）",
                "features": {
                    "keywords": [
                        "医药",
                        "医改",
                        "优质个股",
                        "行业周报",
                        "中性"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【东吴医药】恒瑞深度报告：仿创结合+制剂出口奠基础，创新药龙头拔锚启航开新章",
                "features": {
                    "keywords": [
                        "东吴医药",
                        "恒瑞",
                        "仿创结合",
                        "制剂出口",
                        "创新药",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}